Replies to post #22068 on American Bio Medica Corp (ABMC)

[bk1287]

Well, thankfully we have international distribution then.

[The Rainbow]

Charge whatever the market will bear — honestly.

This is a quote I read recently and is how I have always based the value of my services to my clients.

ABMC's bottom line is based on the cost of distribution and overhead, etc., which we do not know, plus a markup for profit. Speculating or debating on what these costs are at this time, or the availability of the test is fruitless and wearisome. The Q, with some answers, will be filed any day now.

We will get more info on sales, product availability and perhaps even pricing in the filings for Q2.

Then we can extrapolate further investment decisions from there. Buy, sell, strengthen positions, can be decided after the next Q, which will provide some guidance at least for 2020.

I am not following your thoughts on AYTU that was also selling a second test that lost their FDA EUA and the Abbot test that will only be used by first responders and front line workers at this time.

[justbecause516]

According to the article below backlogs and high demand for the products are the name of the game for all in July. So the proof will be in the puddin and not this Q.But we should get something to nibble on for next q
https://www.wsj.com/articles/companies-rush-to-shore-up-covid-19-testing-ahead-of-flu-season-11598788800

[emit]

.20 this week - ya!





emit...